2013
DOI: 10.1186/1753-6561-7-s6-p110
|View full text |Cite
|
Sign up to set email alerts
|

Rec. ST6Gal-I variants to control enzymatic activity in processes of in vitro glycoengineering

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2015
2015
2015
2015

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 3 publications
0
2
0
Order By: Relevance
“…For example, sialyltransferases serve as biomarkers in clinical biochemistry [2]. Recently, also the demand for sialyltransferases applicable in biocatalysis, natural product synthesis, and modification of biotherapeutics has rapidly increased in biotechnological markets [3][4][5][6].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…For example, sialyltransferases serve as biomarkers in clinical biochemistry [2]. Recently, also the demand for sialyltransferases applicable in biocatalysis, natural product synthesis, and modification of biotherapeutics has rapidly increased in biotechnological markets [3][4][5][6].…”
Section: Introductionmentioning
confidence: 99%
“…For example, sialyltransferases serve as biomarkers in clinical biochemistry [2]. Recently, also the demand for sialyltransferases applicable in biocatalysis, natural product synthesis, and modification of biotherapeutics has rapidly increased in biotechnological markets [3][4][5][6].Sialyltransferases (EC 2.4.99.X) are glycosyltransferases, which transfer a sialic acid from an activated sugar donor, usually CMP-Neu5Ac (cytidine-5'-monophospho-b-D-N-acetylneuraminic acid) 1 , to a carbohydrate acceptor molecule. These carbohydrates can be free or attached to a protein or lipid [1,7-10].…”
mentioning
confidence: 99%